Jounce Therapeutics, Inc. Annual Net Income (Loss) Attributable to Parent in USD from 2015 to 2022

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Jounce Therapeutics, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2015 to 2022.
  • Jounce Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2022 was $51M.
  • Jounce Therapeutics, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2022 was -$50.9M, a 44% increase year-over-year.
  • Jounce Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$50.9M, a 44% increase from 2021.
  • Jounce Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$90.9M, a 107% decline from 2020.
  • Jounce Therapeutics, Inc. annual Net Income (Loss) Attributable to Parent for 2020 was -$43.8M, a 177% decline from 2019.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 -$50.9M +$40M +44% Jan 1, 2022 Dec 31, 2022 10-K/A 2023-04-28
2021 -$90.9M -$47M -107% Jan 1, 2021 Dec 31, 2021 10-K/A 2023-04-28
2020 -$43.8M -$101M -177% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-02
2019 $56.8M +$84.2M Jan 1, 2019 Dec 31, 2019 10-K 2021-02-25
2018 -$27.4M -$10.9M -66.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-02-27
2017 -$16.4M -$2.74M -20% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-06
2016 -$13.7M +$14.8M +52% Jan 1, 2016 Dec 31, 2016 10-K 2018-03-08
2015 -$28.5M Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.